Our first priority is the health, wellness and safety of everyone who walks through our doors.
Bryn Mawr Medical Specialists Association is open for medically necessary office visits and procedures only. BMMSA as a corporation is taking all necessary precautions and following public health safety guidelines in regards to the COVID-19 pandemic.
TeleMedicine appointments are now available. Please contact your physicians office for eligibility, additional information, and with any concerns or questions.
As per order of the Commonwealth of Pennsylvania, any person entering our office building is required to wear a face mask at all times. Patients will not be permitted to enter the building without a face mask.
All patients should expect to be phone screened by Bryn Mawr Medical Specialists Association staff for COVID-19 symptoms or exposures prior to their appointment and again upon arrival. Patients should also expect to be temperature screened upon arrival in the office.
If your answer to any of the following questions is “Yes”, we ask that you call to reschedule your appointment.
In the past 14 days, have you developed any fever, cough or shortness of breath?
In the past 14 days, have you developed any of the following new symptoms?
Body aches or muscle pains?
Chills or repeated shaking with chills?
New loss of taste or of smell?
Have you, or anyone you have close contact with, been recently referred for COVID-19 testing?
In the past 14 days, have you traveled outside of PA? If “Yes”, please call the office to notify us of travel BEFORE your appointment. Patients recently returning from travel restricted states or countries will be asked to reschedule their appointment.
For the safety of our staff and other patients, patient family members or companions are not permitted at this time to accompany patients to their appointments (unless medically necessary or the patient is a minor). Bryn Mawr Medical Specialists Association respectfully asks family members or companions to wait outside or safely in their vehicle.
We encourage all of our patients to visit the CDC website and Main Line Health COVID-19 Response website to read more about everyday preventative measures and for the most up to date guidance regarding the Coronavirus (COVID-19). If you are concerned that you may have the Coronavirus (COVID-19), please contact your local Health Departments.
If you have any questions regarding our policy and your appointment, please call your doctor’s office.
Caroline M. Groft-MacFarlane, M.D., Ph.D.
Bryn Mawr Medical Arts Pavilion
825 Old Lancaster Road
Bryn Mawr, PA 19010
6 Lancaster Ave.
Wynnewood, PA 19096
Phone: (610) 642-1090 Fax: (610) 658-5861
Education & Training
1993-97 – B.A., Wellesley College (Biology)
1998-02 – Ph.D.,The Rockefeller University (Molecular Biophysics)
2002-06 – M.D., Weill Medical College of Cornell University
Postgraduate Training and Fellowship Appointments
2006-07 – Intern in Medicine, Mount Sinai Medical Center, New York City
2007-Present – Residency in Dermatology, Hospital of the University of Pennsylvania, Philadelphia
Awards, Honors and Membership in Honorary, Professional and Scientific Societies
2005-06 – Admissions Committee, Cornell Medical College
2006 – Alpha Omega Alpha
2007 – Member, Housestaff Committee, University of Pennsylvania
2007 – Member, American Academy of Dermatology
2008 – AAD Travel Scholarship awardee, to the Chilean national dermatology meeting SOCHIDERM
2009 – Volunteerism Committee, American Academy of Dermatology
Yun S, Groft C, Jambusaria A, and Miller C. Melanocyte:keratinocyte Ratio and the Presence of Pagetoid Melanocytes in Actinic Keratosis and Squamous Cell Carcinoma in Situ Compared to Perilesional Sun-Damaged Skin. Abstract, 2009 ASDS meeting, Phoenix, AZ.
Miller C, Gormley R, Groft C, and Kovarik C. High risk mucosal HPV types in digital SCC. Submitted.
Patel VI, Daniel S, Longo CR, Shrikhande GV, Scali ST, Czismadia E, Groft CM, Shukri T, Motley-Dore C, Ramsey HE, Fisher MD, Grey ST, Arvelo MB, Ferran C. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia. FASEB J. 2006 Jul;20(9):1418-30.
Groft CM, Burley SK. Recognition of eIF4G by Rotavirus NSP3 reveals a basis for mRNA circularization. Mol Cell. 2002 Jun;9(6):1273-1283.
Deo RC*, Groft CM*, Rajashankar KR, Burley SK. Recognition of the Rotavirus mRNA 3’ consensus by an asymmetric NSP3 homodimer. Cell. 2002 Jan;108(1):71-81. *Authors contributed equally.
Groft CM, Beckmann R, Sali A, Burley SK. Crystal structures of ribosome anti-association factor IF6. Nat Struct Biol. 2000 Dec;7(12):1156-64.